CAD 5.38
(3.86%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 591.19 Million USD | -27.64% |
2022 | 817 Million USD | 30.02% |
2021 | 628.37 Million USD | 2771.41% |
2020 | 21.88 Million USD | -80.54% |
2019 | 112.43 Million USD | 3402.78% |
2018 | -3.4 Million CAD | -123.57% |
2017 | 14.44 Million CAD | 167.29% |
2016 | 5.4 Million CAD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | 473.58 Million USD | -19.89% |
2024 Q2 | 444.95 Million USD | -6.05% |
2023 FY | 591.19 Million USD | -27.64% |
2023 Q2 | 815 Million USD | -2.44% |
2023 Q4 | 591.19 Million USD | -16.82% |
2023 Q1 | 835.4 Million USD | 2.25% |
2023 Q3 | 710.7 Million USD | -12.8% |
2022 Q4 | 817 Million USD | -1.22% |
2022 FY | 817 Million USD | 30.02% |
2022 Q1 | 676.69 Million USD | 7.69% |
2022 Q2 | 779.13 Million USD | 15.14% |
2022 Q3 | 827.12 Million USD | 6.16% |
2021 Q1 | 14.28 Million USD | -34.73% |
2021 FY | 628.37 Million USD | 2771.41% |
2021 Q4 | 628.37 Million USD | 397.0% |
2021 Q3 | 126.43 Million USD | 738.48% |
2021 Q2 | 15.07 Million USD | 5.57% |
2020 FY | 21.88 Million USD | -80.54% |
2020 Q4 | 21.88 Million USD | -69.66% |
2020 Q3 | 72.13 Million USD | -21.84% |
2020 Q2 | 92.29 Million USD | -25.74% |
2020 Q1 | 124.27 Million USD | 10.53% |
2019 Q2 | 67.1 Million USD | 103.01% |
2019 Q4 | 112.43 Million USD | 17.29% |
2019 Q3 | 95.85 Million USD | 42.85% |
2019 Q1 | 33.05 Million CAD | 1070.95% |
2019 FY | 112.43 Million USD | 3402.78% |
2018 Q2 | 32.08 Million CAD | 175804.13% |
2018 Q4 | -3.4 Million CAD | 84.27% |
2018 FY | -3.4 Million CAD | -123.57% |
2018 Q1 | -18.26 Thousand CAD | -100.13% |
2018 Q3 | -21.64 Million CAD | -167.44% |
2017 Q4 | 14.44 Million CAD | 44393.08% |
2017 Q1 | 136.31 Thousand USD | 450.89% |
2017 Q3 | -32.6 Thousand CAD | 0.0% |
2017 FY | 14.44 Million CAD | 167.29% |
2016 Q4 | -38.84 Thousand CAD | 0.0% |
2016 FY | 5.4 Million CAD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Aion Therapeutic Inc. | 826.13 Thousand CAD | -71461.998% |
Ayurcann Holdings Corp. | 69.97 Thousand CAD | -844722.018% |
Blueberries Medical Corp. | -805.35 Thousand CAD | 73508.464% |
The BC Bud Corporation | 225.15 Thousand CAD | -262476.115% |
BioNxt Solutions Inc. | 4.53 Million CAD | -12949.288% |
CordovaCann Corp. | 6.13 Million CAD | -9542.773% |
Christina Lake Cannabis Corp. | 4.62 Million CAD | -12674.078% |
Captor Capital Corp. | -5.41 Million CAD | 11026.747% |
City View Green Holdings Inc. | 1.49 Million CAD | -39359.868% |
1CM Inc. | 3.31 Million CAD | -17733.893% |
Global Hemp Group Inc. | 3.55 Million CAD | -16543.516% |
Greenway Greenhouse Cannabis Corporation | 14.48 Million CAD | -3980.181% |
IM Cannabis Corp. | 11.96 Million CAD | -4839.41% |
Lobe Sciences Ltd. | 192.35 Thousand CAD | -307255.342% |
Maple Leaf Green World Inc. | 2.47 Million CAD | -23797.583% |
Mountain Valley MD Holdings Inc. | -5.91 Million CAD | 10094.894% |
Nextleaf Solutions Ltd. | -449.15 Thousand CAD | 131725.081% |
Ovation Science Inc. | 143.76 Thousand CAD | -411122.403% |
Pharmadrug Inc. | 1.2 Million CAD | -48893.281% |
Captiva Verde Wellness Corp. | 186.26 Thousand CAD | -317304.703% |
RAMM Pharma Corp. | -4.71 Million CAD | 12647.48% |
RIV Capital Inc. | -101.38 Million CAD | 683.132% |
Revive Therapeutics Ltd. | -797.85 Thousand CAD | 74198.891% |
Red White & Bloom Brands Inc. | 259.87 Million CAD | -127.489% |
SLANG Worldwide Inc. | 20.83 Million CAD | -2738.021% |
1933 Industries Inc. | 16.47 Million CAD | -3487.701% |
Red Light Holland Corp. | -13.56 Million CAD | 4459.457% |
Top Strike Resources Corp. | 13.24 Million CAD | -4362.438% |
Xebra Brands Ltd. | -102.41 Thousand CAD | 577340.329% |
Adastra Holdings Ltd. | 2.2 Million CAD | -26719.96% |